The Silent Enemy: Insulin Resistance

PRESS RELEASE Helsinki 17 April 2018 – The MealPlanner, the MedTech company creating solutions in the fight against diet related diseases has begun the development of their new App, MIRA Health-My Insulin Resistance App with the support of an EU-PERMIDES grant & collaboration with the National Netherlands Insurance within the Sparklab program.

Insulin Resistance (IR) is undiagnosed in 90% of the population that suffers from this precursor to serious, life-changing, diet centered disease. IR is the precursor of such health problems as polycystic ovary syndrome (PCOS), infertility, heart disease and diabetes, all of which have reached epidemic proportions, globally.

The MealPlanner combats insulin resistance in three ways:

• Create awareness about IR. Even medical professionals confuse IR with pre-diabetes so public education is important for everyone. The outcome of this education is to get people to diagnose and test for IR from time to time just as we do with breast and prostate cancers.
• With the PERMIDES grant we are creating a self-diagnostic tool to make preliminary diagnoses easy and free for all.
• Our App supports the efforts of people to manage their IR with proper nutrition. The only way to prevent the onset of more serious disease is to learn healthy and mindful nutrition.

In addition to the EU grant the project has received its first 100k seed investment.

The Mealplanner is seeking further public participation in their efforts to educate the public about diet based disease and give them the tools needed to fight for healthy solutions. To learn more about the company and see further investment possibility click here.

Contact:
Sophie Michelin
CEO, The MealPlanner
sophie@themealplanner.net
+36 30 7385130

Mikko Savolainen
Head of communications, Invesdor Ltd.
mikko.savolainen@invesdor.com
+358 40 747 5205
 

The MealPlanner in brief:
The MealPlanner is a team of passionate nutritionists, medical experts and culinary chefs believing that many of our 21st century diseases are caused by malnutrition. We create nutrition MedTech API solutions that can be integrated with existing Applications & software. More information at themealplanner.com.
 

Invesdor in brief:
A financial technology (fintech) company founded in Finland in 2012, Invesdor operates an online investment platform that connects ambitious European growth companies with investors worldwide. Invesdor has helped raise more than 48 million euros for more than a hundred businesses. Its clients include private and publicly traded companies from Finland, the UK, Sweden, Norway and Denmark as well as investors from more than 70 countries. Invesdor has offices in Helsinki, Stockholm and London. More information at invesdor.com.